568
Views
55
CrossRef citations to date
0
Altmetric
Pancreas

The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice

, , , , , & show all
Pages 602-609 | Received 03 Feb 2013, Accepted 14 Feb 2013, Published online: 11 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Elham Bakhtiari, Azar Hosseini, Mohammad Taher Boroushaki & Seyed Hadi Mousavi. (2016) Angiotensin II receptor antagonist olmesartan and NF-kappaB inhibitor as cytotoxic and apoptotic agents in MCF-7 human cell line. Journal of Chemotherapy 28:4, pages 314-320.
Read now
Panagiota Papanagnou, Panagiotis Baltopoulos & Maria Tsironi. (2015) Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists’ arsenal. Therapeutics and Clinical Risk Management 11, pages 807-819.
Read now
Elham Bakhtiari, Azar Hosseini, Mohammad Taher Boroushaki & Seyed Hadi Mousavi. (2015) Synergistic, cytotoxic and apoptotic activities of olmesartan with NF-κB inhibitor against HeLa human cell line. Toxicology Mechanisms and Methods 25:8, pages 614-621.
Read now
Atsushi Masamune, Eriko Nakano, Shin Hamada, Tetsuya Takikawa, Naoki Yoshida & Tooru Shimosegawa. (2014) Alteration of the microRNA expression profile during the activation of pancreatic stellate cells. Scandinavian Journal of Gastroenterology 49:3, pages 323-331.
Read now

Articles from other publishers (51)

Eduarda Ribeiro, Bárbara Costa, Francisco Vasques-Nóvoa & Nuno Vale. (2023) In Vitro Drug Repurposing: Focus on Vasodilators. Cells 12:4, pages 671.
Crossref
Scott W. Keith, Vittorio Maio, Hwyda A. Arafat, Matthew Alcusky, Thomas Karagiannis, Carol Rabinowitz, Harish Lavu & Daniel Z. Louis. (2022) Angiotensin blockade therapy and survival in pancreatic cancer: a population study. BMC Cancer 22:1.
Crossref
Fereshteh Asgharzadeh, Kiarash Roustai Geraylow, Majid Khazaei, Mohammadreza Nassiri, Seyed Mahdi Hassanian, Gordon A Ferns & Amir Avan. (2022) Angiotensin-converting Enzyme Inhibitors and Angiotensin Receptor Blockers as Potential Therapeutic Options for Pancreatic Cancer. Current Cancer Drug Targets 22:10, pages 785-795.
Crossref
Tomas Koltai, Stephan Joel Reshkin, Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Khalid Omer Alfarouk & Rosa Angela Cardone. (2022) Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review. Cancers 14:10, pages 2486.
Crossref
Tiago M. A. Carvalho, Daria Di Molfetta, Maria Raffaella Greco, Tomas Koltai, Khalid O. Alfarouk, Stephan J. Reshkin & Rosa A. Cardone. (2021) Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches. Cancers 13:23, pages 6135.
Crossref
. (2021) Roles of renin-angiotensin system in the regulation of prostate cancer bone metastasis: a critical review. annals of urologic oncology.
Crossref
Moudhi Almutlaq, Abir Abdullah Alamro, Hassan S. Alamri, Amani Ahmed Alghamdi & Tlili Barhoumi. (2021) The Effect of Local Renin Angiotensin System in the Common Types of Cancer. Frontiers in Endocrinology 12.
Crossref
Andrew Cannon, Christopher Michael Thompson, Rakesh Bhatia, Katharine Anne Armstrong, Joyce Christopher Solheim, Sushil Kumar & Surinder Kumar Batra. (2021) Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma. Journal of Gastroenterology 56:8, pages 689-703.
Crossref
Marcel A. Heinrich, Ahmed M.R.H. Mostafa, Jennifer P. Morton, Lukas J.A.C. Hawinkels & Jai Prakash. (2021) Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models. Advanced Drug Delivery Reviews 174, pages 265-293.
Crossref
Shu-Yang Li, Yoichi Yoshida, Eiichi Kobayashi, Masaaki Kubota, Tomoo Matsutani, Seiichiro Mine, Toshio Machida, Yoshiro Maezawa, Minoru Takemoto, Koutaro Yokote, Yoshio Kobayashi, Hirotaka Takizawa, Mizuki Sata, Kazumasa Yamagishi, Hiroyasu Iso, Norie Sawada, Shoichiro Tsugane, Sohei Kobayashi, Kazuyuki Matsushita, Fumio Nomura, Hisahiro Matsubara, Makoto Sumazaki, Masaaki Ito, Satoshi Yajima, Hideaki Shimada, Katsuro Iwase, Hiromi Ashino, Hao Wang, Kenichiro Goto, Go Tomiyoshi, Natsuko Shinmen, Rika Nakamura, Hideyuki Kuroda, Yasuo Iwadate & Takaki Hiwasa. (2021) Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis. Scientific Reports 11:1.
Crossref
Ramiz S. Ahmad, Timothy D. Eubank, Slawomir Lukomski & Brian A. Boone. (2021) Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer. Biomolecules 11:6, pages 901.
Crossref
Mohammad-Hassan Arjmand. (2020) Elucidating the Association Between the Upregulation of Angiotensin Type 1-Receptors and the Development of Gastrointestinal Malignancies. Journal of Gastrointestinal Cancer 52:2, pages 399-406.
Crossref
Rami Alzhrani, Hashem O. Alsaab, Kushal Vanamala, Ketki Bhise, Katyayani Tatiparti, Ayatakshi Barari, Samaresh Sau & Arun K. Iyer. (2021) Overcoming the Tumor Microenvironmental Barriers of Pancreatic Ductal Adenocarcinomas for Achieving Better Treatment Outcomes. Advanced Therapeutics 4:6, pages 2000262.
Crossref
Yu‐Tsai Lin, Hung‐Chen Wang, Ming‐Hsien Tsai, Yan‐Ye Su, Ming‐Yu Yang & Chih‐Yen Chien. (2021) Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma. Cancer 127:10, pages 1606-1619.
Crossref
Faran Polani, Patrick M Grierson & Kian-Huat Lim. (2021) Stroma-targeting strategies in pancreatic cancer: Past lessons, challenges and prospects. World Journal of Gastroenterology 27:18, pages 2105-2121.
Crossref
Friederike Jungmann, Georgios A. Kaissis, Sebastian Ziegelmayer, Felix Harder, Clara Schilling, Hsi-Yu Yen, Katja Steiger, Wilko Weichert, Rebekka Schirren, Ishan Ekin Demir, Helmut Friess, Markus R. Makowski, Rickmer F. Braren & Fabian K. Lohöfer. (2021) Prediction of Tumor Cellularity in Resectable PDAC from Preoperative Computed Tomography Imaging. Cancers 13:9, pages 2069.
Crossref
Yang Wu, Chun Zhang, Kuirong Jiang, Jens Werner, Alexandr V. Bazhin & Jan G. D’Haese. (2021) The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives. Frontiers in Oncology 10.
Crossref
Mohammad Asif Emon, Daniel Domingo-Fernández, Charles Tapley Hoyt & Martin Hofmann-Apitius. (2020) PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures. BMC Bioinformatics 21:1.
Crossref
Kévin Louault, Rong-Rong Li & Yves A. DeClerck. (2020) Cancer-Associated Fibroblasts: Understanding Their Heterogeneity. Cancers 12:11, pages 3108.
Crossref
Bolun Jiang, Li Zhou, Jun Lu, Yizhi Wang, Chengxi Liu, Lei You & Junchao Guo. (2020) Stroma-Targeting Therapy in Pancreatic Cancer: One Coin With Two Sides?. Frontiers in Oncology 10.
Crossref
Marcos V. Perini, Rhynelle S. Dmello, Tracy L. Nero & Ashwini L. Chand. (2020) Evaluating the benefits of renin-angiotensin system inhibitors as cancer treatments. Pharmacology & Therapeutics 211, pages 107527.
Crossref
Krishna Sriram, Cristina Salmerón, Shu Z. Wiley & Paul A. Insel. (2020) GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets . British Journal of Pharmacology 177:11, pages 2434-2455.
Crossref
Srinivasa P. Pothula, Romano C. Pirola, Jeremy S. Wilson & Minoti V. Apte. (2020) Pancreatic stellate cells: Aiding and abetting pancreatic cancer progression. Pancreatology 20:3, pages 409-418.
Crossref
Jakob Kirkegård, Frank Viborg Mortensen & Deirdre Cronin-Fenton. (2019) Antihypertensive drugs and pancreatic cancer risk in patients with chronic pancreatitis: a Danish nationwide population-based cohort study. British Journal of Cancer 121:7, pages 622-624.
Crossref
Jonas Schnittert, Ruchi Bansal & Jai Prakash. (2019) Targeting Pancreatic Stellate Cells in Cancer. Trends in Cancer 5:2, pages 128-142.
Crossref
Kelly J. Lafaro & Laleh G. Melstrom. (2019) The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment. The American Journal of Pathology 189:1, pages 44-57.
Crossref
Ozkan Kanat & Hulya Ertas. (2018) Shattering the castle walls: Anti-stromal therapy for pancreatic cancer. World Journal of Gastrointestinal Oncology 10:8, pages 202-210.
Crossref
Zipeng Lu, Maximilian Weniger, Kuirong Jiang, Stefan Boeck, Kai Zhang, Alexander Bazhin, Yi Miao, Jens Werner & Jan G. D’Haese. (2018) Therapies Targeting the Tumor Stroma and the VEGF/VEGFR Axis in Pancreatic Ductal Adenocarcinoma: a Systematic Review and Meta-Analysis. Targeted Oncology 13:4, pages 447-459.
Crossref
Andrew Cannon, Christopher Thompson, Bradley R. Hall, Maneesh Jain, Sushil Kumar & Surinder K. Batra. (2018) Desmoplasia in pancreatic ductal adenocarcinoma: insight into pathological function and therapeutic potential. Genes & Cancer 9:3-4, pages 78-86.
Crossref
Elham Ahmadian, Ahmad Yari Khosroushahi, Aziz Eftekhari, Safar Farajnia, Hossein Babaei & Mohammad Ali Eghbal. (2018) Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2. Biomedicine & Pharmacotherapy 99, pages 939-946.
Crossref
Suolin Zhang & Yayan Wang. (2018) Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway. Oncology Letters.
Crossref
Sujit Suklabaidya, Pujarini Dash, Biswajit Das, Voddu Suresh, Prakash K Sasmal & Shantibhusan Senapati. (2018) Experimental models of pancreatic cancer desmoplasia. Laboratory Investigation 98:1, pages 27-40.
Crossref
Nand Kumar Singh, Alok Kumar Yadav, Preeti Sirohi, Manjoo Rani, Saurabh Saraswat, Manish Pratap Singh, Ashutosh Mani & Sameer Srivastava. 2018. Anticancer Plants: Mechanisms and Molecular Interactions. Anticancer Plants: Mechanisms and Molecular Interactions 165 196 .
Matthias Pinter & Rakesh K. Jain. (2017) Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. Science Translational Medicine 9:410.
Crossref
Laleh G. Melstrom, Marcela D. Salazar & Don J. Diamond. (2017) The pancreatic cancer microenvironment: A true double agent. Journal of Surgical Oncology 116:1, pages 7-15.
Crossref
Naoki Yoshida, Atsushi Masamune, Shin Hamada, Kazuhiro Kikuta, Tetsuya Takikawa, Fuyuhiko Motoi, Michiaki Unno & Tooru Shimosegawa. (2017) Kindlin-2 in pancreatic stellate cells promotes the progression of pancreatic cancer. Cancer Letters 390, pages 103-114.
Crossref
Janaiah Kota, Julie Hancock, Jason Kwon & Murray Korc. (2017) Pancreatic cancer: Stroma and its current and emerging targeted therapies. Cancer Letters 391, pages 38-49.
Crossref
Victoria Mandilaras, Nathaniel Bouganim, Hui Yin, Jamil Asselah & Laurent Azoulay. (2016) The use of drugs acting on the renin–angiotensin system and the incidence of pancreatic cancer. British Journal of Cancer 116:1, pages 103-108.
Crossref
Srinivasa P. Pothula, Zhihong Xu, David Goldstein, Romano C. Pirola, Jeremy S. Wilson & Minoti V. Apte. (2016) Key role of pancreatic stellate cells in pancreatic cancer. Cancer Letters 381:1, pages 194-200.
Crossref
Hyoung Shik Kim, Seung Hwan Ryu, Hye In Kim, Seung Hee Cho, Jeong Hun Lee, Byung Suk Han, Kyung Rok Lee & Sang Hyun Moh. (2016) A novel nicotinoyl peptide, nicotinoyl-LVH, for collagen synthesis enhancement in skin cells. Journal of Applied Biological Chemistry 59:3, pages 239-242.
Crossref
Jae Chon You, Hae Soo Jung, Hyoung Shik Kim, Jeong Hun Lee & Sang Hyun Moh. (2016) The Effect of Roots Extract from Potentilla chinensis as Cosmeceutical Material. Journal of Applied Biological Chemistry 59:1, pages 13-17.
Crossref
M.V. Apte, Z. Xu, S. Pothula, D. Goldstein, R.C. Pirola & J.S. Wilson. (2015) Pancreatic cancer: The microenvironment needs attention too!. Pancreatology 15:4, pages S32-S38.
Crossref
Yousuke Nakai, Hiroyuki Isayama, Takashi Sasaki, Naminatsu Takahara, Kei Saito, Kazunaga Ishigaki, Tsuyoshi Hamada, Suguru Mizuno, Koji Miyabayashi, Keisuke Yamamoto, Dai Mohri, Hirofumi Kogure, Natsuyo Yamamoto, Hideaki Ijichi, Keisuke Tateishi, Minoru Tada & Kazuhiko Koike. (2014) The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients. Journal of Cancer Research and Clinical Oncology 141:5, pages 933-939.
Crossref
Maarten F. Bijlsma & Hanneke W. M. van Laarhoven. (2015) The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal. Cancer and Metastasis Reviews 34:1, pages 97-114.
Crossref
Minoti V. Apte, Romano C. Pirola & Jeremy S. Wilson. 2015. Stellate Cells in Health and Disease. Stellate Cells in Health and Disease 271 306 .
Jonathan Haqq, Lynne M Howells, Giuseppe Garcea, Matthew S Metcalfe, Will P Steward & Ashley R Dennison. (2014) Pancreatic stellate cells and pancreas cancer: Current perspectives and future strategies. European Journal of Cancer 50:15, pages 2570-2582.
Crossref
Daniel Öhlund, Ela Elyada & David Tuveson. (2014) Fibroblast heterogeneity in the cancer wound. Journal of Experimental Medicine 211:8, pages 1503-1523.
Crossref
Shin Hamada, Atsushi Masamune & Tooru Shimosegawa. (2013) Inflammation and pancreatic cancer: disease promoter and new therapeutic target. Journal of Gastroenterology 49:4, pages 605-617.
Crossref
Zhihong Xu. (2014) Pancreatic cancer and its stroma: A conspiracy theory. World Journal of Gastroenterology 20:32, pages 11216.
Crossref
Yousuke Nakai, Hiroyuki Isayama, Hideaki Ijichi, Takashi Sasaki, Naminatsu Takahara, Yukiko Ito, Saburo Matsubara, Rie Uchino, Hiroshi Yagioka, Toshihiko Arizumi, Tsuyoshi Hamada, Koji Miyabayashi, Suguru Mizuno, Keisuke Yamamoto, Hirofumi Kogure, Natsuyo Yamamoto, Kenji Hirano, Naoki Sasahira, Keisuke Tateishi, Minoru Tada & Kazuhiko Koike. (2013) A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2. Investigational New Drugs 31:5, pages 1294-1299.
Crossref
E. O. Taratukhin. (2013) ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES. Cardiovascular Therapy and Prevention 12:3, pages 55-57.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.